What to know about COVID 19?

This 1918 flu pandemic is also called the ‘Spanish flu’ and known to have caused approximately 40 million deaths in a single year! The world currently is facing such a pandemic situation once again. The question that is in the minds of almost every person across the globe is, will there be something of this large to take place once again. Thankfully, scientists from all over the world are negative about it. The fact cannot be denied that the world does face a tough situation at this point of time. Epidemiologists and doctors are of the strong belief that the world is now in a much better position and has the essential resource required to combat this pandemic. They are trying to come up with Recombinant Coronavirus antigens to treat patients affected with COVID 19.

Reasons for global scientific community to show optimism

1.Scientists are aware as to how this virus is to be detected correctly. Since 13th January, RT-PCR assay is available worldwide to identify the virus. The conducted to determine COVID 19 is found to be refined, while its specificity and sensitivity evaluated.

2.Scientists are aware of its identity. It was in June 1981 that the initial AIDS cases had been described. It took about two years for scientists to identify the exact causes of the virus and pinpoint the virus. On 31st December 2019, the initial cases were reported of severe pneumonia in China. It got identified by 7th January 2020 and on 10th, genome became available. This new 2B group coronavirus belongs to SARS and hence, derived the name SARSCoV2. This disease rather is referred to as COVID 19. The virus is rather associated with bat coronavirus. According to genetic tests, recent natural origin had been confirmed, between late Nov’19 & early Dec’19. Even though the viruses mutate to survive, frequency of mutation is not found to be much high. 2019-nCoV’s phylogenetic evaluation of complete genomes & Betacoronavirus representative The Lancet, which is 2019 novel coronavirus epidemiology and Genomic characterization. These are implications for receptor binding and virus origins.

3.80 percent of all cases related to this virus are mild in nature. Mild or no symptoms are caused by this disease in about 81% of all cases reported until date. The rest 14% experience severe pneumonia, while for the other 5%, life can become fatal or critical.

4.Situation improving in China: The Chinese government has stepped up to take immediate actions and strong measures to contain the virus and to nullify new case reporting. Isolation measures and strong control for over weeks is now bearing fruit. Every day, the number of cases diagnosed is decreasing. Suspect numbers in the hospital is found to have dropped to just 2.4%, while the total affected figure has reduced to about half of what it was on 8th February. China has managed to introduce Coronavirus Protein for treating patients. Hence, they are recording more number of fully recovered patients affected from this virus than those still infected. This automatically suggests overcoming of the epidemic. Several stores which were shut down last month had also been reopened for the public.

5.The creation and introduction of COVID-19 antigens has helped infected people to get cured. More patients are getting cured than deaths reported by about 13 times and this proportion are only found to be increasing. For details on the disease visit https://www.genemedi.net/

6.It is possible to inactivate the virus. Using ethanol solution comprising of 62% to 71% alcohol, sodium hypochlorite (0% to 1% bleach) or hydrogen peroxide (0% to 5% hydrogen peroxide), it is possible inactivate the virus effectively.

7.Minors are less affected than other types of virus. As per hospital and doctor reports across the globe, children are affected just about 3%, while morality among under 40 people just being 0.2%. Symptoms noticed in minors are quite mild, such that they are unnoticed, the reason why virus may be spread to the others easily.

8.There are presently available prototype vaccines including Recombinant 2019 nCoV. The world has the necessary resources to create new vaccines. There are multiple projects undertake to combat this new virus. Groups are engaged on different vaccine projects to fight similar viruses, with the objective to change viruses. Their development can be prolonged due to essential toxicity evidence, safety, side effects, protective efficacy and immunogenicity. It may take several months or perhaps years. However, there are already available few prototypes.

9.Over 80 clinical trials combined with antiviral are in the creation. Vaccines are preventative and can treat those who are sick already. Clinical trials are being conducted for testing treating coronavirus. Such antivirals are used to treat other infections and have been approved already, which means, they are safe to be used for treatment purpose.

Getting to know about this virus will help people in general to stay safe.